COVID-19 in cystic fibrosis patients

Author:

Kondratyeva E. I.1ORCID,Krasovsky S. A.2ORCID,Kashirskaya N. Yu.1ORCID,Amelina E. L.3ORCID,Zhekaite E. K.1ORCID,Sherman V. D.1ORCID,Simonova O. I.4ORCID,Gorinova Yu. V.5ORCID,Boitsova E. V.6,Mukhina M. A.7,Butyugina I. N.3,Makarova M. A.8,Malakhov A. B.9

Affiliation:

1. Academician N.P.Bochkov Federal Medical Genetic Academic Center, Russian Academy of Science

2. Academician N.P.Bochkov Federal Medical Genetic Academic Center, Russian Academy of Science; Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia

3. Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia

4. Federal Academic Centre of Children’s Health, Healthcare Ministry of Russia; Morozov State Pediatric Teaching Hospital, Moscow Healthcare Department; I.M.Sechenov First Moscow State Medical University (Sechenov University), Healthcare Ministry of Russia

5. Federal Academic Centre of Children’s Health, Healthcare Ministry of Russia

6. Saint Petersburg State Pediatric Medical University, Healthcare Ministry of Russia

7. Morozov State Pediatric Teaching Hospital, Moscow Healthcare Department:

8. N.I.Pirogov Federal Russian National Research Medical University, Healthcare Ministry of Russia

9. I.M.Sechenov First Moscow State Medical University (Sechenov University), Healthcare Ministry of Russia

Abstract

Since the beginning of the COVID-19 epidemic, the European cystic fibrosis society (ECFS) has decided to launch a special ECFS-COVID-19 program to collect information on the of COVID-19 characteristics in the patients with cystic fibrosis (CF). The results of the program should help timely and efficiently provide the patients with CF with the necessary care. Initially, it was assumed that COVID-19 would be severe in CF patients. The aim. Тo assess the prevalence and characteristics of COVID-19 in patients with cystic fibrosis (CF) in the Russian Federation (RF). Methods. 6 cases (4 children and 2 adults) of COVID-19 in Russian CF patients were analyzed. Results. There are 405,843 infected with SARS-CoV-2 in Russia, the incidence of coronavirus infection in Russia was 1.4 cases per 1 thousand people. According to the Ministry of Health of the RF, as of December 2019, there were 3,931 patients with CF (2,823 children and 1,108 adults). The incidence of COVID-19 was 1.5 per 1000 patients with CF (1.4 : 1,000 for children and 1.8 : 1,000 for adults). The incidence was not higher than in the General population. The diagnosis of COVID-19 was confirmed in 4 boys and 2 women, 3 of the patients were infected with Pseudomonas aeruginosa and 2 – with Achromobacter spp. Mild disease was seen in 5 patients including all the children. Pneumonia was registered in 3 patients. One child with COVID-19 had abdominal syndrome. 2 patients – 1 adult and 1 child – needed in-patient care. Additional antibiotics were given to 4 patients, 2 of them received i/v antibiotics. One adult patient was on the lung transplantation waiting list. This woman had long-term oxygen therapy and BiPAP noninvasive respiratory support before the infection with SARS-CoV-2, FEV1 was 24 %pred. Conclusion. Despite the fact that patients with CF are at risk of severe COVID-19, to date, in the described cases, COVID-19 infection has not led to a significant deterioration of the symptoms of CF. Not a single fatal outcome in Russian patients with CF has been recorded.

Publisher

Scientific and Practical Reviewed Journal Pulmonology

Subject

Pulmonary and Respiratory Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3